| Entry |
|
| Name |
Albendazole (JAN/USP/INN); Albenza (TN) |
| Product |
|
| Generic |
|
| Formula |
C12H15N3O2S
|
| Exact mass |
265.0885
|
| Mol weight |
265.33
|
| Structure |

|
| Simcomp |
|
| Remark |
| Therapeutic category: | 6429 |
| Product (DG01022): | D00134<JP/US> |
|
| Efficacy |
Anthelmintic |
| Disease |
|
| Comment |
Benzimidazole derivative
Inhibiton of microtubule-organizing
|
| Target |
fumarate reductase |
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P02 ANTHELMINTICS
P02C ANTINEMATODAL AGENTS
P02CA Benzimidazole derivatives
P02CA03 Albendazole
D00134 Albendazole (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antiparasitics
Anthelmintics
Albendazole
D00134 Albendazole (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
64 Parasitics (systemic)
642 Anthelmintics
6429 Others
D00134 Albendazole (JAN/USP/INN)
Antimicrobials [BR:br08307]
Antiparasitics
Antinematodal agents
Benzimidazole derivatives
D00134 Albendazole (JAN/USP/INN) <JP/US>
|
| Other DBs |
|
| LinkDB |
|
| KCF data |
ATOM 18
1 C8x C 21.9100 -15.5400
2 C8y C 21.9100 -16.9400
3 C8x C 23.1700 -17.6400
4 C8y C 24.3600 -16.9400
5 C8y C 24.3600 -15.5400
6 C8x C 23.1700 -14.8400
7 N5x N 25.6900 -17.3600
8 C8y C 26.5300 -16.2400
9 N4x N 25.6900 -15.0500
10 S2a S 20.7200 -17.6400
11 C1b C 19.5300 -16.9400
12 C1b C 18.2700 -17.6400
13 C1a C 17.0800 -16.9400
14 N1b N 27.9300 -16.2400
15 C7a C 28.6300 -17.4300
16 O7a O 30.0300 -17.4300
17 C1a C 30.7300 -18.6200
18 O6a O 27.9300 -18.6200
BOND 19
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 1
11 2 10 1
12 10 11 1
13 11 12 1
14 12 13 1
15 8 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 15 18 2
|